SG/CALL/FRESENIUS MEDICAL CARE/64/0.1/21.06.24 Share Price

Warrant

DE000SV9V175

Delayed Deutsche Boerse AG 14:47:08 14/06/2024 BST
0.001 EUR 0.00% Intraday chart for SG/CALL/FRESENIUS MEDICAL CARE/64/0.1/21.06.24
Current year-93.75%
Date Price Change
14/06/24 0.001 0.00%
13/06/24 0.001 0.00%
12/06/24 0.001 0.00%
11/06/24 0.001 0.00%
10/06/24 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 02:47 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Société Générale Société Générale
WKN SV9V17
ISINDE000SV9V175
Date issued 19/07/2023
Strike 64
Maturity 21/06/2024 (4 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.16
Lowest since issue 0.001

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.63 EUR
Average target price
39.97 EUR
Spread / Average Target
+3.48%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW